BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashraf MU, Kim Y, Kumar S, Seo D, Ashraf M, Bae YS. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines (Basel) 2021;9:171. [PMID: 33670630 DOI: 10.3390/vaccines9020171] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Valenzuela-fernández A, Cabrera-rodriguez R, Ciuffreda L, Perez-yanes S, Estevez-herrera J, González-montelongo R, Alcoba-florez J, Trujillo-gonzález R, García-martínez de Artola D, Gil-campesino H, Díez-gil O, Lorenzo-salazar JM, Flores C, Garcia-luis J. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.1052436] [Reference Citation Analysis]
2 de Matos PH, da Silva TP, Mansano AB, Gancedo NC, Tonin FS, Pelloso FC, Petruco MV, de Melo EB, Fernandez-llimos F, Sanches ACC, de Mello JCP, Chierrito D, de Medeiros Araújo DC. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review. Inflamm Res 2022. [DOI: 10.1007/s00011-022-01642-7] [Reference Citation Analysis]
3 Miteva D, Peshevska-Sekulovska M, Snegarova V, Batselova H, Alexandrova R, Velikova T. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic. World J Virol 2022; 11(5): 221-236 [DOI: 10.5501/wjv.v11.i5.221] [Reference Citation Analysis]
4 Chen T, Hsu M, Lee M, Chou C. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses 2022;14:1188. [DOI: 10.3390/v14061188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Zhang L, Yao L, Guo Y, Li X, Ma L, Sun R, Han X, Liu J, Huang J. Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice. Front Microbiol 2022;13:792532. [DOI: 10.3389/fmicb.2022.792532] [Reference Citation Analysis]
6 Kar S, Devnath P, Emran TB, Tallei TE, Mitra S, Dhama K. Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges. Immun Inflamm Dis 2022;10:e604. [PMID: 35349752 DOI: 10.1002/iid3.604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dhama K, Dhawan M, Tiwari R, Emran TB, Mitra S, Rabaan AA, Alhumaid S, Alawi ZA, Al Mutair A. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Hum Vaccin Immunother 2022;:1-11. [PMID: 35258416 DOI: 10.1080/21645515.2022.2045853] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
8 Muangman S, Pimainog Y, Kunaratnpruk S, Kanchanaphum P, Deiana G. The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay. Journal of Environmental and Public Health 2022;2022:1-7. [DOI: 10.1155/2022/2350522] [Reference Citation Analysis]
9 Patenaude B, Ballreich J. Estimating & Comparing Greenhouse Gas Emissions for Existing Intramuscular COVID-19 Vaccines and a Novel Thermostable Oral Vaccine. The Journal of Climate Change and Health 2022. [DOI: 10.1016/j.joclim.2022.100127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Singh DD, Sharma A, Lee H, Yadav DK. SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy. Front Cell Infect Microbiol 2022;12:839170. [DOI: 10.3389/fcimb.2022.839170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
11 Kudlay D, Svistunov A. COVID-19 Vaccines: An Overview of Different Platforms. Bioengineering 2022;9:72. [DOI: 10.3390/bioengineering9020072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Tirziu A, Paunescu V. Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach. Vaccines 2022;10:218. [DOI: 10.3390/vaccines10020218] [Reference Citation Analysis]
13 Drozdzik A, Drozdzik M. Oral Pathology in COVID-19 and SARS-CoV-2 Infection-Molecular Aspects. Int J Mol Sci 2022;23:1431. [PMID: 35163355 DOI: 10.3390/ijms23031431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Focosi D, Maggi F, Casadevall A. Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence. Viruses 2022;14:187. [DOI: 10.3390/v14020187] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
15 Karczmarzyk K, Kęsik-brodacka M. Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines. Pathogens 2022;11:117. [DOI: 10.3390/pathogens11020117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Hafiz I, Illian DN, Meila O, Utomo ARH, Susilowati A, Susetya IE, Desrita D, Siregar GA, Basyuni M. Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review. Vaccines (Basel) 2022;10:82. [PMID: 35062743 DOI: 10.3390/vaccines10010082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
17 Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy PH, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines 2021;9:1740. [PMID: 34829969 DOI: 10.3390/biomedicines9111740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
18 Alamer E, Alhazmi A, Qasir NA, Alamer R, Areeshi H, Gohal G, Qadri M, Hashem AM, Algaissi A. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia. Vaccines (Basel) 2021;9:1297. [PMID: 34835228 DOI: 10.3390/vaccines9111297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
19 Keikha R, Hashemi-Shahri SM, Jebali A. The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta. Sci Rep 2021;11:21308. [PMID: 34716391 DOI: 10.1038/s41598-021-00830-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Marinović B, Miše J, Jukić IL, Bukvić Mokos Z. Pemphigus-The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic. Biomedicines 2021;9:1555. [PMID: 34829784 DOI: 10.3390/biomedicines9111555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang S, Li L, Yan F, Gao Y, Yang S, Xia X. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects. Vaccines (Basel) 2021;9:1082. [PMID: 34696190 DOI: 10.3390/vaccines9101082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jeeva S, Kim KH, Shin CH, Wang BZ, Kang SM. An Update on mRNA-Based Viral Vaccines. Vaccines (Basel) 2021;9:965. [PMID: 34579202 DOI: 10.3390/vaccines9090965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Todorov SD, Tagg JR, Ivanova IV. Could Probiotics and Postbiotics Function as "Silver Bullet" in the Post-COVID-19 Era? Probiotics Antimicrob Proteins 2021. [PMID: 34386940 DOI: 10.1007/s12602-021-09833-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Forchette L, Sebastian W, Liu T. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics. Curr Med Sci 2021. [PMID: 34241776 DOI: 10.1007/s11596-021-2395-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
25 Shin CH, Kim KH, Jeeva S, Kang SM. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021;10:1412. [PMID: 34204163 DOI: 10.3390/cells10061412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, Nourwali I, Qasem F, Dar-Odeh N. Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines. Vaccines (Basel) 2021;9:577. [PMID: 34205917 DOI: 10.3390/vaccines9060577] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 41.0] [Reference Citation Analysis]
27 Sampath V, Rabinowitz G, Shah M, Jain S, Diamant Z, Jesenak M, Rabin R, Vieths S, Agache I, Akdis M, Barber D, Breiteneder H, Chinthrajah S, Chivato T, Collins W, Eiwegger T, Fast K, Fokkens W, O'Hehir RE, Ollert M, O'Mahony L, Palomares O, Pfaar O, Riggioni C, Shamji MH, Sokolowska M, Jose Torres M, Traidl-Hoffmann C, van Zelm M, Wang Y, Zhang L, Akdis CA, Nadeau KC. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy 2021;76:1640-60. [PMID: 33811364 DOI: 10.1111/all.14840] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 32.0] [Reference Citation Analysis]
28 Beeraka NM, Tulimilli SV, Karnik M, Sadhu SP, Pragada RR, Aliev G, Madhunapantula SV. The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). Biomed Res Int 2021;2021:8160860. [PMID: 34159203 DOI: 10.1155/2021/8160860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
29 Jicsinszky L, Martina K, Cravotto G. Cyclodextrins in the antiviral therapy. J Drug Deliv Sci Technol 2021;64:102589. [PMID: 34035845 DOI: 10.1016/j.jddst.2021.102589] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
30 Kim KH, Bhatnagar N, Jeeva S, Oh J, Park BR, Shin CH, Wang BZ, Kang SM. Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice. Vaccines (Basel) 2021;9:316. [PMID: 33805473 DOI: 10.3390/vaccines9040316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]